OBJECTIVE: Risk of stillbirth in women with pregestational diabetes (PGDM) is approximately 2-fold higher than the non-diabetic pregnant population. ACOG recommends initiation of antepartum fetal surveillance (ANFS) between 32-34 weeks' gestation for most patients with PGDM. We sought toidentify maternal and fetal factors associated with earlier stillbirth in women with PGDM and to compare the cumulative rates of stillbirths by GA in women with PGDM and other factors associated with earlier stillbirth in this population. STUDY DESIGN: Population-based retrospective cohort study of all stillbirths in the U.S. during the year 2014. Frequency of stillbirths in women who were diagnosed antepartum (non-laboring) were stratified by GA, 20-44 weeks, according to PGDM status. Cause of fetal death was obtained from ICD-10 codes. Maternal, obstetric, and fetal characteristics in women with PGDM were compared between those with early ( 32 weeks) vs late (>32 weeks) stillbirth. Multivariate logistic regression estimated the relative association of various maternal, obstetric, and fetal factors on risk for early stillbirth among women with PGDM. RESULTS: Of 14,362 women diagnosed with antepartum (nonlaboring) stillbirth during 2014 in the US, 591 (4.1%) women had PGDM. The median GA at diagnosis was 33 (IQR 26,37) weeks with nearly half (47.2%) occurring 32 wksand 52.8% after 32 wks. The cumulative rates of stillbirth by GA among women with PGDM were 22.6, 35.0, 47.2, and 55.2% at 24, 28, 32, 34 weeks' gestation respectively. Factors associated with early stillbirth among women with PGDM included lagging fetal growth as evidenced by small for gestational age (SGA<10 th %) birthweight (aRR 2.6, CI 1.6-4.1) and chronic HTN (aRR 1.7, CI 1.0-2.9). Over 50% of stillbirths occurred before 34 wks in women with PGDM, before 31 wks in women with PGDM plus chronic HTN, and before 30 weeks in women with PGDM plus SGA birthweight. Despite a median occurrence of stillbirth at 33 wks among women with PGDM, 12.9% of stillbirths attributed to "maternal diabetes" occurred between 28-32 weeks' gestation; when ANFS is typically not recommended for this population. CONCLUSION: Stillbirth occurs at earlier GA among women with PGDM and additional risk factors including fetal growth restriction and chronic HTN despite current guidelines recommending ANFS at 32-34 weeks. Recommendations to initiate ANFS between 32-34 weeks may fail to prevent a significant proportion of stillbirths in this population.
OBJECTIVE:
To compare hemorrhagic morbidity among pregnancies affected by invasive placentation with and without co-existing placenta previa STUDY DESIGN: We conducted a retrospective cohort study of deliveries at a tertiary care center from 1997 to 2017 with histologically-confirmed invasive placentation. The primary outcome was transfusion of any blood product; secondary outcomes were transfusion of specific blood products, estimated blood loss, number of units transfused and intensive care unit admission. Risk ratios (RR) and 95% confidence intervals (CI) are reported.
RESULTS:
We identified 105 pregnancies complicated by invasive placentation, 47 with previa and 58 without. Women with previa were more likely to have an antenatal diagnosis of invasive placentation, a greater depth of invasion and to deliver at an earlier gestational age (all p<0.001). After adjusting for depth of invasion, women with pregnancies complicated by previa were more likely to receive a blood transfusion compared to those without (RR: 2.0; 95% CI: 1.3-3.1). Women with previa were more likely to receive packed red blood cells, platelets and cryoprecipitate, but not fresh frozen plasma or cell saver (Table 1) . Compared to deliveries among women without previa, those with previa were complicated by larger median estimated blood loss and more units of packed red blood cells transfused (both p0.03), though the number of units of fresh frozen plasma and cryoprecipitate were similar (both p0.53). Women with previa were more likely to have a hysterectomy (crude RR 2.7; 95% CI: 1.8-3.8) and be admitted to the intensive care unit (RR: 3.3; 95% CI: 1.1-9.6, adjusted for depth of invasion). CONCLUSION: Among pregnancies complicated by invasive placentation, those with co-existing placenta previa experienced greater hemorrhagic morbidity as compared to those without. Given the increased morbidity, pregnancies complicated by both invasive placentation and placenta previa warrant multi-disciplinary preoperative planning and care.
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Oregon Health & Science University, Portland, OR OBJECTIVE: The incidence of placenta accreta has increased dramatically in the last several decades. Scheduled cesarean hysterectomy at a multidisciplinary care facility has been shown to improve outcomes, however the ideal timing of delivery remains uncertain based on limited analyses. We sought to determine the optimal gestational week to schedule a cesarean hysterectomy among women with suspected placenta accreta spectrum. STUDY DESIGN: A decision analytic model was created using TreeAgePro software to compared outcomes of scheduled cesarean hysterectomy between 32 and 37 weeks of gestation. We calculated the rate of spontaneous delivery, antepartum hemorrhage requiring emergent cesarean hysterectomy and the risk of intrauterine fetal demise (IUFD) during the period of expectant management for each advancing week. Access to a multidisciplinary team at tertiary care facilities was incorporated into the model. Only scheduled deliveries were assumed to have adequate time to administer antenatal corticosteroids, and we calculated reduced rates of respiratory distress
